Anxiety treatment serving Miami — exposure-based CBT, in-house psychiatry.

RECO Health's Delray Beach campus sits 65 minutes north of Brickell via I-95 — close enough for family involvement, far enough that most Miami clients stay on campus in sober-living rather than commuting through the trigger-dense social scene at home. Anxiety care is protocol-driven: GAD-7, PDSS, LSAS, and Y-BOCS at intake; disorder-specific ERP, interoceptive, or in-vivo exposure with a trained therapist rather than a generic anxiety group; SSRIs at anxiety-effective doses managed by in-house psychiatry; and a deliberate clinical policy against benzodiazepines in clients with any substance use history.

From Brickell, Coral Gables, or Coconut Grove, RECO Health’s Delray Beach campus sits about 50 miles north up I-95 — roughly 65 minutes off-peak and longer through the Fort Lauderdale corridor. Most Miami clients admitted for anxiety treatment stay in on-site sober-living residences rather than commuting daily; the geographic separation from Brickell’s bar scene, Wynwood nightlife, and the general pace of Miami is part of the clinical rationale, not incidental to it. Anxiety disorders in this population rarely present in isolation — co-occurring alcohol use, stimulant misuse, sleep dysregulation, and mood instability shape how each treatment plan is actually built.

Disorder-specific assessment before treatment starts

“Anxiety” is a symptom, not a diagnosis, and treating it as one is where most outpatient anxiety care fails. RECO Health’s intake battery separates the presenting picture into its component disorders using validated instruments: the GAD-7 for generalized anxiety severity, the Panic Disorder Severity Scale (PDSS) for panic frequency and functional impairment, the Liebowitz Social Anxiety Scale (LSAS) for social phobia, and the Y-BOCS for obsessive-compulsive symptom burden. Trauma screening runs alongside using the PCL-5, because untreated PTSD often drives what looks like generalized anxiety on a first pass, and ADHD is screened with the ASRS when concentration complaints dominate.

The distinction matters at the treatment-planning level. Generalized anxiety disorder responds to a different exposure structure than OCD; social anxiety treatment collapses if it is folded into a generic “anxiety group” without disorder-specific graded exposure. Every plan RECO writes names the primary DSM-5-TR diagnosis, the co-occurring conditions, and the outcome measure that will be re-administered at defined intervals throughout the episode of care. If the GAD-7 or Y-BOCS score is not moving by week four, the plan changes rather than the client being told to be patient.

SSRI pharmacotherapy at anxiety-appropriate doses

Sertraline, escitalopram, paroxetine, and fluoxetine are all FDA-approved for one or more anxiety disorders, and first-line pharmacotherapy starts there. Anxiety-effective dosing typically sits at the upper end of the depression range — sertraline titrated toward 150-200 mg, escitalopram to 20 mg, paroxetine to 40-60 mg — with a deliberately slow initial titration to avoid the activation, jitteriness, and sleep disruption that drive early SSRI discontinuation. The first two weeks are often the hardest; RECO’s psychiatry team explains this in advance so clients do not stop the medication before it has a chance to work.

Where the SSRI helps but not enough, buspirone augments the GAD response without sedation or dependence risk. Hydroxyzine is available as-needed to blunt breakthrough anxiety without benzodiazepine exposure. Propranolol has a defined role in situational performance anxiety — public speaking, court appearances, family confrontations in early recovery — where the physiological symptoms are the disabling piece. SNRIs (venlafaxine, duloxetine) are second-line for GAD when SSRIs fail or are not tolerated, and treatment-resistant presentations are considered for adjunctive rTMS or ketamine on a case-by-case basis.

Exposure-based CBT is the therapy that actually works

For every anxiety disorder in the DSM-5-TR, the evidence base points to exposure-based cognitive behavioral therapy rather than open-ended supportive talk therapy. RECO Health’s individual therapy is protocol-driven. For OCD, that means Exposure and Response Prevention (ERP) — a structured, hierarchical, therapist-guided protocol in which the client faces the obsessional trigger and refrains from the compulsion, session after session, until the anxiety extinguishes. For panic disorder, interoceptive exposure to feared bodily sensations (spinning, controlled hyperventilation, elevated heart rate) breaks the catastrophic misinterpretation loop that maintains the disorder.

For social anxiety, treatment runs on graded in-vivo exposures paired with cognitive restructuring — the client actually does the feared thing (initiates conversations, orders food at the counter, gives a short talk in group) rather than only discussing it in session. Acceptance and Commitment Therapy (ACT) elements are folded in where experiential avoidance dominates, and DBT skills — distress tolerance, mindfulness — reinforce rather than replace the exposure work. Group programming supports the individual protocol; it does not substitute for it. Generic process group does not treat OCD.

Why RECO Health does not lean on benzodiazepines

Alprazolam, clonazepam, and lorazepam relieve acute anxiety quickly — which is precisely the problem. The fast relief blunts the extinction learning that makes exposure therapy work; the brain never gets the chance to learn that the feared situation is survivable without the pill. Published meta-analyses have documented worse long-term CBT outcomes in patients maintained on benzodiazepines during treatment. Beyond the therapy interference, benzodiazepines carry meaningful dependence and overdose risk in clients with any co-occurring substance use disorder — a large share of RECO’s population.

When situational bridging is genuinely needed — the first two weeks on an SSRI, a specific high-stakes exposure, acute insomnia disrupting the therapy schedule — hydroxyzine, gabapentin, or a short course of low-dose propranolol cover most clinical use cases without opening a dependence trajectory. Clients arriving on established benzodiazepine prescriptions are not stopped abruptly; a deliberate taper using a long-half-life agent (typically diazepam or clonazepam) is negotiated as a shared clinical decision over weeks.

What the first week looks like for a client from Miami

Admission from Miami typically begins with a phone assessment and verification of benefits before the client leaves home. Transportation from Brickell, Aventura, or Pinecrest to Delray Beach is coordinated by RECO’s admissions team, and MIA or FLL pickup is arranged for out-of-town family. The first 72 hours on campus include a full psychiatric evaluation, medical history and physical, the anxiety assessment battery described above, and — where indicated — medically monitored withdrawal management guided by the CIWA-Ar for alcohol or COWS for opioids before the anxiety work can meaningfully begin.

Individual therapy starts in the first week. Exposure hierarchies are built collaboratively; nothing is sprung on the client. Medication decisions are shared, with informed consent on expected side effects and time-to-response. Family contact, with signed release, typically begins within the first seven to ten days, and the primary therapist becomes the point of contact for care coordination back to any established Miami-based psychiatrist or therapist.

Insurance and step-down planning back to Miami

RECO Health is in-network with most major commercial carriers relevant to South Florida: Florida Blue, Blue Cross Blue Shield, Aetna, Cigna, UnitedHealthcare, and Humana. Verification of benefits is completed before admission so the family receives a written estimate — deductible, coinsurance, days initially authorized at each level of care — rather than a surprise bill weeks in.

PHP and IOP are the standard levels of care for primary anxiety presentations; residential and detox are added where a co-occurring substance use disorder or acute safety concern requires it. Length of stay is driven by ASAM Criteria dimensions and by clinical response on the outcome measures, not by a fixed calendar. Most Miami clients spend the residential and PHP portion on campus in Delray Beach and step down to IOP either on-site or through a warm handoff to a vetted Miami-based outpatient provider.

Serving residents of: Brickell, Coral Gables, Coconut Grove, Aventura, Pinecrest.